Moderna $mRNA vs Arbutus $ABUS Oral arguments appeal. Three experts weigh in and all agree ABUS will prevail and be do royalties from Moderna. Part of the argument is standing and the reason Arbutus has not sued Moderna is that if ABUS sued mRNA that would give Moderna a defense for standing. Arbutus drew three very pro patent judges who support the patent office decisions. Patent 069 they feel will be rubber stamped meaning the court will affirm the patent office decision within the next 10 days. Patent 435 may be a written decision taking 2 to 4 months. On October 12th the patent office will issue a much broader patent to Arbutus. Currently Arbutus has a contract with Moderna. Patent appeals 80% are affirmed 10% are mixed and 10% are reversed. All good news for ABUS we should start seeing a rise in our share price today. GL ALL$Moderna, Inc.(MRNA)$